Navigation Links
Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting
Date:6/1/2008

clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the implication of the materials presented at the ASCO meeting with respect to REOLYSIN(R), the Company's expectations related to the results of trials investigating delivery of REOLYSIN(R), and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting
2. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
3. Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R)
4. Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent
5. Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting
6. Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
7. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
8. Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting
9. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
10. Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells
11. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Today BioSpace , the leading life sciences employment and ... the life sciences community in Illinois , ... , Michigan , Minnesota , ... and Wisconsin . BioMidwest is ... job postings on BioSpace originating in this region in 2013. The life ...
(Date:7/31/2014)... There,s a good reason people over 60 are not ... ages and weakens with time, making the elderly prone ... San Francisco research team now has discovered a reason ... for the inability of blood-forming cells to maintain blood ... identified molecular defects that could be restored for rejuvenation ...
(Date:7/31/2014)... and even the entire body to visualize long-range connections ... been a long-time dream of biologists. A study published ... journal Cell has now made that dream ... bodies, and human tissue biopsies transparent, while keeping the ... the way for a better understanding of brain-body interactions, ...
(Date:7/31/2014)... -- Chemists at Indiana University Bloomington have described ... fashion, a development with potential value for the ... transistors and photovoltaic cells. , Their paper, "Anion-Induced ... Solids and 2D Self-Assembled Crystals," has been published ... of the Royal Society of Chemistry. It is ...
Breaking Biology Technology:Midwest Biotech Leaders Featured On BioSpace Map 2Key to aging immune system is discovered 2See-through organs and bodies will accelerate biomedical discoveries 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3
... PITTSBURGH, Sept. 23 As the world converges on Pittsburgh ... are clear skies and the lack of the traditional, stereotypical ... they are greeted by a region that for the past ... to a service economy centered on the development and commercialization ...
... , , , ... the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology ... intent with verIDentia SL of Macanet De La Selva, Girona, ... were not disclosed. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ...
... Biological Sciences Research Council (BBSRC) have uncovered what happens ... found that the important proteins that make up the ... enzyme called cathepsin L. Scientists now have to take ... ensure the exciting field of nanomedicine can progress. The ...
Cached Biology Technology:Pittsburgh Life Sciences Greenhouse Demonstrates a Region's Economic Resilience 2Pittsburgh Life Sciences Greenhouse Demonstrates a Region's Economic Resilience 3Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 2Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 3Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 4Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product 5New discovery reveals fate of nanoparticles in human cells 2
(Date:7/31/2014)... the United States, natural-gas production from shale rock ... 2007. Yet scientists still do not fully understand ... to a report in the journal Frontiers ... gas extraction continues to vastly outpace scientific examination, ... organizations and institutions, including Princeton University, concluded that ...
(Date:7/31/2014)... Foundation (NSF), counters a widely-held scientific view that ... that certain Arctic lakes store more greenhouse gases ... The study, published this week in the journal ... occur as permafrost thaws and creates surface depressions ... was previously frozen land into lakes. , The ...
(Date:7/31/2014)... long been known that biomass burning burning ... a ritual , slash-and-burn agriculture and wildfires ... , But until the release of a new ... Professor Mark Z. Jacobson, the degree of that ... research, detailed in a paper published July 30 ...
Breaking Biology News(10 mins):'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 2'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 3Certain Arctic lakes store more greenhouse gases than they release 2Stanford professor finds that wildfires and other burns play bigger role in climate change 2Stanford professor finds that wildfires and other burns play bigger role in climate change 3Stanford professor finds that wildfires and other burns play bigger role in climate change 4
... kid goats recognise each other,s calls soon after the mothers ... reveals. The study, published in the journal Animal ... the ability of goats to recognise the individual differences. ... Mary,s School of Biological and Chemical Sciences found that mother ...
... smoke flavoring made from hickory and other wood a ... and home kitchens may get a competitor that seems ... to a new study in ACS, Journal of Agricultural ... liquid smoke produced from rice hulls, the hard, inedible coverings ...
... For diagnosing head and neck ailments, tests that ... don,t. Otolaryngologists have a wide range of techniques available ... ultrasound. CT uses significant radiation and MRI a lower ... does not require injection of radioactive contrast material and ...
Cached Biology News:Lessening the dangers of radiation 2
... Express Cloning Checker Kits provide two ... after transformation without time-consuming plasmid preparation. By ... I, all you need to do is ... bacteria directly from the transformation plates into ...
... Services include subcloning of gene in ... cells, isolation and plaque purification of ... virus stock for one clone, protein ... insect cell culture. Expected yield and ...
Request Info...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Biology Products: